$PRA beats — and it’s all about execution.
Q4 EPS came in at 82 cents, topping estimates as expenses declined and investment income rose, even with lower premiums. That’s margin discipline showing up in the numbers.
Can expense control keep driving upside here?
Get the full breakdown 👉 https://www.zacks.com/stock/news/2875293/proassurance-q4-earnings-beat-estimates-on-declining-expenses?cid=sm-stocktwits-2-2875293-teaser-35165&ADID=SYND_STOCKTWITS_TWEET_2_2875293_TEASER_35165
$PRA earnings surprise with a 115.8% YoY rise! 🔥
📈 Adjusted operating income of 82 cents per share vs. 22-cent estimate
📉 Revenue dipped 5.6% YoY but still beat consensus by 3.9%
🔍 Zacks Rank #1 (Strong Buy) underscores bullish sentiment
Discover the full story here 👉 https://www.zacks.com/stock/news/2875293/proassurance-q4-earnings-beat-estimates-on-declining-expenses?cid=sm-stocktwits-2-2875293-body-35127&ADID=SYND_STOCKTWITS_TWEET_2_2875293_BODY_35127
$PRA Q4 '25 Earnings Results & Recap
• Reported GAAP EPS of $0.64 up 106.45% YoY
• Reported revenue of $269.64M down -7.05% YoY
• ProAssurance anticipates closing the merger transaction with The Doctors Company by June 30, 2026, and expects continued pressure on workers' compensation rates for 2026.
$PRA is a clinical-stage biotech focused on the central nervous system; its pipeline is in early development, representing a long-duration, high-risk bet.
$HRTG, $PRA, $HCI: Why these insurers are on fire YTD!
$HRTG up 125.5% YTD, boosted by a booming E&S business and strategic growth moves.
$PRA surges 50% YTD, driven by premium growth and strategic acquisitions.
$HCI jumps 56.5% YTD, leveraging diverse business activities and solid growth scores.
Discover what’s fueling their momentum here 👉 https://www.zacks.com/stock/news/2756547/3-pc-insurance-stocks-that-have-rallied-more-than-25-ytd?cid=sm-stocktwits-2-2756547-body-13959&ADID=SYND_STOCKTWITS_TWEET_2_2756547_BODY_13959
Insurance rally — 3 names up 25%+ YTD
$HRTG, $PRA, and $HCI have shrugged off higher catastrophe losses, beating not just their industry but also the Zacks S&P 500 composite and the Finance sector.
See the full breakdown here 👉 https://www.zacks.com/stock/news/2756547/3-pc-insurance-stocks-that-have-rallied-more-than-25-ytd?cid=sm-stocktwits-2-2756547-teaser-13954&ADID=SYND_STOCKTWITS_TWEET_2_2756547_TEASER_13954
$PRA Outstanding article that hits the mark on PRA's current state. So if you want to refresh your PRA insights or learn about PRA from scratch, this is a must read. https://beyondspx.com/quote/PRA/analysis/proassurance-a-disciplined-specialty-insurer-s-strategic-evolution-towards-value-creation-nyse-pra
$PRA beats Q2 earnings estimates — what drove the surprise? 📈
ProAssurance's adjusted operating income hit 52 cents per share, crushing the Zacks Consensus Estimate of 19 cents, thanks to rising investment income and lower expenses. However, lower premiums in Specialty P&C and Reinsurance segments partially offset gains.
Full breakdown here 👉 https://www.zacks.com/stock/news/2698158/proassurance-q2-earnings-beat-estimates-on-declining-expenses?cid=sm-stocktwits-2-2698158-body-7225&ADID=SYND_STOCKTWITS_TWEET_2_2698158_BODY_7225
$PRA just beat Q2 earnings — here’s the driver you didn’t expect 📈
Lower expenses and higher investment income more than made up for softer premiums, pushing results above estimates.
Full breakdown here 👉 https://www.zacks.com/stock/news/2698158/proassurance-q2-earnings-beat-estimates-on-declining-expenses?cid=sm-stocktwits-2-2698158-teaser-7222&ADID=SYND_STOCKTWITS_TWEET_2_2698158_TEASER_7222
$PRA | Current Active Merger, Acquisition, and Liquidation Opportunities: An Overview
"ProAssurance merger with TDC faces potential regulatory hurdles, creating a short opportunity with limited downside and significant upside." - Special Situation Investments (Special Situation Investments)
Read more: https://www.smartkarma.com/insights/current-active-merger-acquisition-and-liquidation-opportunities-an-overview
